{"nctId":"NCT00621517","briefTitle":"Bupropion and Restless Legs Syndrome","startDateStruct":{"date":"2008-02"},"conditions":["Restless Legs Syndrome"],"count":60,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Bupropion"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Bupropion","otherNames":["Wellbutrin"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* clinical diagnosis of Restless Legs Syndrome\n* Severity Scale score 15 or higher\n\nExclusion Criteria:\n\n* History of seizures\n* History of alcohol use greater than 2 drinks per day or occasional binges of 5 or more drinks per day\n* Suicidal thoughts/ideations\n* Inability to return for follow up appointments at 3 and 6 weeks\n* Lack of access to telephone\n* Eating disorder\n* Age less than 18\n* Pregnancy\n* Unwillingness or inability to discontinue any RLS medications","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in International Restless Legs Syndrome Study Group (IRLSSG) Severity Scale.","description":"Scale ranges from 0 to 40 points with higher scores being associated with more severe symptoms of restless legs syndrome. There are 10 questions, with points of 0 to 4 per question. The change in IRLSSG score from baseline is recorded at three and six weeks.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.4","spread":"10.1"},{"groupId":"OG001","value":"-7.6","spread":"7.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.8","spread":"10.0"},{"groupId":"OG001","value":"-6.0","spread":"6.6"}]}]}]},{"type":"PRIMARY","title":"Clinical Global Impression - Improvement Scale","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"PRIMARY","title":"Ordinal Scale (i.e., 1-8) of Symptom Severity","description":null,"paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":29},"commonTop":["nausea"]}}}